Exosome - based drug delivery system: a novel approach in targeted therapy
Future Journal of Pharmaceuticals and Health Sciences · 11.05.2026 · 6 (2) · 123-140
DOI: 10.26452/fjphs.v6i2.573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Journal of Pharmaceuticals and Health Sciences, online erschienen am 11.05.2026. Verfasst von {"name":"Kalpana Narapareddy","email":"dwarakanadhareddyperam@gmail.com","aff und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Exosome - based drug delivery has emerged as a transformative approach in modern nanomedicine offering a biologically sophisticated alternative to conventional synthetic nanocarriers. Exosomes are nanoscale extracellular vesicles (30 – 150 nm) naturally secret ed by cells and play a critical role in intercellular communication by transporting proteins, lipids and nucleic acids. Their intrinsic properties including biocompatibility, low immunogenicity, ability to cross biological barriers such as the blood – brain barrier and natural targeting capability make them highly promising candidates for precision drug delivery.The biosynthesis chemical makeup and classification of exosomes within extracellular vesicles are all covered in detail in this article. It also cove rs recent developments in drug loading techniques like electroporation incubation and endogenous engineering as well as isolation and characterization methods. The pharmacokinetic properties of exosomes and surface modification strategies for targeted deli very are also investigated. The therapeutic potential of exosomes is highlighted across multiple disease areas, including oncology, neurology, cardiology, and immunotherapy. Additionally emerging developments such as plant - derived exosome - like nanoparticle s and hybrid nanocarrier systems are explored. Despite significant progress, challenges related to large - scale manufacturing loading efficiency standardization and regulatory approval remain critical barriers to clinical translation. Overall exosomes repre sent a highly promising platform for next - generation targeted therapeutics with ongoing research expected to bridge the gap between experimental success and clinical application.
Zitieren
APA
Narapareddy","email":"dwarakanadhareddyperam@gmail.com","aff, N., Peram","email":"dwarakanadhareddyperam@gmail.com","aff, N. R., & Dugasani","email":"dwarakanadhareddyperam@gmail.com","affili, N. (2026). Exosome - based drug delivery system: a novel approach in targeted therapy. Future Journal of Pharmaceuticals and Health Sciences, 6(2), 123-140. https://doi.org/10.26452/fjphs.v6i2.573
Vancouver
Narapareddy","email":"dwarakanadhareddyperam@gmail.com","aff N, Peram","email":"dwarakanadhareddyperam@gmail.com","aff NR, Dugasani","email":"dwarakanadhareddyperam@gmail.com","affili N. Exosome - based drug delivery system: a novel approach in targeted therapy. Future Journal of Pharmaceuticals and Health Sciences. 2026;6(2):123-140. doi:10.26452/fjphs.v6i2.573
BibTeX
@article{Narapareddyemaildwarakanadhareddyperamgmailcomaff2026,
author = {Narapareddy","email":"dwarakanadhareddyperam@gmail.com","aff, "name":"Kalpana and Peram","email":"dwarakanadhareddyperam@gmail.com","aff, "name":"Dwarkanadha Reddy and Dugasani","email":"dwarakanadhareddyperam@gmail.com","affili, "name":"Swarnalatha},
title = {Exosome - based drug delivery system: a novel approach in targeted therapy},
journal = {Future Journal of Pharmaceuticals and Health Sciences},
year = {2026},
volume = {6},
number = {2},
pages = {123--140},
doi = {10.26452/fjphs.v6i2.573}
}
EUVIMED